FHL-5 Activators encompass a spectrum of chemical compounds that indirectly augment the functional activity of FHL-5 via diverse signaling pathways and biological processes. Forskolin and IBMX, through their ability to elevate intracellular cAMP levels, activate protein kinase A (PKA), which can phosphorylate a range of substrates. This phosphorylation can enhance FHL-5's functional activity by promoting its coactivator functions within transcriptional complexes, bolstering gene expression regulation. Similarly, Sphingosine-1-phosphate, by activating G protein-coupled receptors, initiates a cascade of signaling events that could facilitate the coactivation roles of FHL-5 by influencing transcriptional regulation. PMA, as a PKC activator, and LY294002's inhibition of PI3K potentially shift the cellular signaling balance, indirectly promoting FHL-5's role in gene expression without affecting its own expression levels.
FurtherFHL-5 Activators encompass a spectrum of chemical compounds that indirectly augment the functional activity of FHL-5 via diverse signaling pathways and biological processes. Forskolin and IBMX, through their ability to elevate intracellular cAMP levels, activate protein kinase A (PKA), which can phosphorylate a range of substrates. This phosphorylation can enhance FHL-5's functional activity by promoting its coactivator functions within transcriptional complexes, bolstering gene expression regulation. Similarly, Sphingosine-1-phosphate, by activating G protein-coupled receptors, initiates a cascade of signaling events that could facilitate the coactivation roles of FHL-5 by influencing transcriptional regulation. PMA, as a PKC activator, and LY294002's inhibition of PI3K potentially shift the cellular signaling balance, indirectly promoting FHL-5's role in gene expression without affecting its own expression levels.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG132, a proteasome inhibitor, could enhance FHL-5 activity by stabilizing proteins that participate in the same transcriptional regulatory complexes as FHL-5, indirectly enhancing its coactivator function. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Epigallocatechin Gallate, through its action as a kinase inhibitor, may enhance FHL-5 activity by modulating signaling pathways that affect transcription factors and coactivators interacting with FHL-5. |